» Articles » PMID: 26334052

No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting

Overview
Journal Clin Infect Dis
Date 2015 Sep 4
PMID 26334052
Citations 280
Authors
Affiliations
Soon will be listed here.
Abstract

Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population.

Citing Articles

The mChoice App, an mHealth Tool for the Monitoring of Preexposure Prophylaxis Adherence and Sexual Behaviors in Young Men Who Have Sex With Men: Usability Evaluation.

Dos Santos F, Brin M, Tanner M, Galindo C, Schnall R JMIR Hum Factors. 2025; 12:e59780.

PMID: 40019786 PMC: 11887583. DOI: 10.2196/59780.


PrEP Use in a US National Sample of Trans Men and Other Transmasculine People Who Have Sex With Men: A Longitudinal Analysis.

Carneiro P, Radix A, Golub S, Grosskopf N, Grov C J Acquir Immune Defic Syndr. 2025; 97(4):357-363.

PMID: 39808073 PMC: 11733312. DOI: 10.1097/QAI.0000000000003492.


Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis.

Traeger M, Leyden W, Volk J, Silverberg M, Horberg M, Davis T JAMA Intern Med. 2025; 185(3):273-281.

PMID: 39761062 PMC: 11877173. DOI: 10.1001/jamainternmed.2024.7186.


Medical chart-reported alcohol consumption, substance use, and mental health issues in association with HIV pre-exposure prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men.

Shuper P, Joharchi N, Varatharajan T, Bogoch I, Loutfy M, El-Helou P BMC Public Health. 2024; 24(1):3487.

PMID: 39696067 PMC: 11658148. DOI: 10.1186/s12889-024-20934-7.


Randomized controlled trial of a pilot PrEP linkage intervention for individuals leaving incarceration in a southern state: Design and baseline characteristics.

Horton H, Marshall S, Gu M, Tody B, Jackson T, Zaller N PLoS One. 2024; 19(12):e0312667.

PMID: 39621654 PMC: 11611198. DOI: 10.1371/journal.pone.0312667.


References
1.
Wilton J, Senn H, Sharma M, Tan D . Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review. HIV AIDS (Auckl). 2015; 7:125-36. PMC: 4422285. DOI: 10.2147/HIV.S50025. View

2.
Marcus J, Glidden D, Mayer K, Liu A, Buchbinder S, Amico K . No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One. 2013; 8(12):e81997. PMC: 3867330. DOI: 10.1371/journal.pone.0081997. View

3.
Grant R, Anderson P, McMahan V, Liu A, Amico K, Mehrotra M . Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014; 14(9):820-9. PMC: 6107918. DOI: 10.1016/S1473-3099(14)70847-3. View

4.
Cassell M, Halperin D, Shelton J, Stanton D . Risk compensation: the Achilles' heel of innovations in HIV prevention?. BMJ. 2006; 332(7541):605-7. PMC: 1397752. DOI: 10.1136/bmj.332.7541.605. View

5.
Bernstein K, Marcus J, Nieri G, Philip S, Klausner J . Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr. 2009; 53(4):537-43. DOI: 10.1097/QAI.0b013e3181c3ef29. View